Beximco Pharmaceuticals Limited
BXPHARMA · DSE · Pharmaceuticals · US listing: BXPHARMA (London Stock Exchange AIM, not a US ADR)
About the company
Beximco Pharmaceuticals is a leading pharmaceutical manufacturer and exporter in Bangladesh, producing a broad range of generic formulations and APIs. The company has a notable regulatory footprint, having received approvals from the UK MHRA and other international regulatory bodies. It is part of the larger Beximco Group.
| Exchange | DSE |
| Ticker | BXPHARMA |
| Sector | Pharmaceuticals |
| US listing | BXPHARMA (London Stock Exchange AIM, not a US ADR) |
| Indicative market cap USD | $500.00M |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
Trades in the US as BXPHARMA (London Stock Exchange AIM, not a US ADR), available through most US brokerage accounts.
On its home market (DSE), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Dhaka Stock Exchange — official exchange listing
Availability information only. Not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Bangladesh
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only. Not investment advice. Verify with the exchange, the company's filings and your broker.